The condition known as von Willebrand disease (vWD) is a mild to a moderate hemorrhagic disorder that is most commonly caused by a mutation in a coagulation factor known as the von Willebrand factor ...
Results showed the median ABR for all bleeds was reduced by 54.7%. The Food and Drug Administration (FDA) has approved Vonvendi ® (von Willebrand factor [recombinant]) for routine prophylaxis to ...
Safety and efficacy of Vonvendi with or without recombinant factor VIII (FVIII) treatment in elective surgical procedures in patients aged ≥18 years diagnosed with severe von Willebrand disease, was ...
MONDAY, Sept. 8, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved expanded use of Vonvendi (von Willebrand factor [recombinant]) for routine prophylactic use in adults with ...
Vonvendi is a lab-made version of von Willebrand factor (VWF), a protein your body needs for blood to clot. Affecting more than 3 million people in the U.S, von Willebrand disease (VWD) is a common ...
von Willebrand Disease (vWD) is one of the most common congenital bleeding disorders, affecting ~1%* of the world’s population. An accurate diagnosis can be very challenging due to the heterogeneity ...
VWD already provides a range of FX data from TPI to customers of its Market Manager platform, including data on 300 US Treasury bills, notes and bonds with maturities of up to 30 years, which the ...
Could your heavy flow be cause for concern? Sherri Ozawa, MSN, RN, tells The Post that serious blood loss during menstruation could be a symptom of von Willebrand disease, a blood disorder that ...
Von Willebrand disease (vWD) is the most common inherited bleeding disorder and affects approximately 1% of the population. This disease is due to a deficiency of Von Willebrand factor (vWF), which is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback